AUTLAutolus Therapeutics plc
$1.77+18% 1Y
$1.77
$1.2152 weeks$2.54
Is the price fair?
What AUTL's price assumes
Autolus Therapeutics plc did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 3.97× revenue.
3.97
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 3.37
Price / book · as of 2026-Q1
Details›
- Price / bookas of 2026-Q1
- 3.37
- EV / EBIToperating margin −211%: the multiple describes the denominator
- not meaningful
- Market capitalisation
- $470M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.